NA

Natarajan Arun

Director Whole-Time Director DIN 03077219
DIN 03077219 First appointment Mar 2010 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Natarajan Arun

Data last updated:

Natarajan Arun was a Whole-Time Director at Regenix Drugs Limited (2012–2018) and Managing Director at Supermed Pharmacy Limited (from 2010). The companies operate in Healthcare.

DIN 03077219
Primary Designation Whole-Time Director
Industry Healthcare
First Appointment 20 Mar 2010
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Regenix Drugs Limited U24232TN2007PLC063446
Whole-Time Director15 Apr 20122007₹188 Cr (FY 2024)Active
Supermed Pharmacy Limited U52310TN2007PLC065888
Managing Director20 Mar 20102007Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Supermed Pharmacy Limited
Regenix Drugs Limited
Premium access

Shareholding and investment profile for Natarajan Arun

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Natarajan Arun

Natarajan Arun was first appointed on 20 Mar 2010 as Managing Director at Supermed Pharmacy Limited. The most recent appointment on record is 15 Apr 2012 at Regenix Drugs Limited.

Natarajan Arun held 2 earlier board appointments: Regenix Drugs Limited (Whole-Time Director, 15 Apr 2012 to 13 Aug 2018); Supermed Pharmacy Limited (Managing Director, from 20 Mar 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available